COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

The EMA’s safety committee (PRAC) concluded that a warning about unusual blood clots with low blood platelets should be added as a potential adverse effect of treatment (very rare), but that overall benefit-risk remains positive.

Source:

European Medicines Agency